Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

计划入组 5,154 人 · 首次发布于 2016 年 8 月 19 日

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

计划入组 240 人 · 首次发布于 2026 年 7 月 20 日

Finasteride, Dutasteride and Insulin Action

计划入组 12 人 · 首次发布于 2013 年 8 月 14 日

aldose reductase inhibitors (Kowa)

thioredoxin reductase 1 inhibitors (cancer)

HMG-CoA reductase inhibitors (cancer)

Cutia Therapeutics Receives NMPA Approval for Topical Dutasteride Clinical Trial in Androgenetic Alopecia

Dayspring Pharma's CG2001 Foam Shows 50% Efficacy Improvement in Phase II Androgenetic Alopecia Trial

Govorestat: FDA Approval Status and Its Role in Treating Galactosemia